121 related articles for article (PubMed ID: 5073104)
21. [Experiences with Lysodren treatment of Cushing's syndrome in dogs].
Opitz M; Lettow E; Loppnow H; Grevel V
Tierarztl Prax; 1983; 11(4):507-20. PubMed ID: 6658774
[No Abstract] [Full Text] [Related]
22. Evaluation and treatment of Cushing's syndrome.
Nieman LK; Ilias I
Am J Med; 2005 Dec; 118(12):1340-6. PubMed ID: 16378774
[TBL] [Abstract][Full Text] [Related]
23. [A case of Cushing's disease treated with o,p'-DDD].
Kaneko K; Saito T; Fujioka T; Sugita Y; Takai K
Horumon To Rinsho; 1982 Oct; 30(10):1071-6. PubMed ID: 7165981
[No Abstract] [Full Text] [Related]
24. [Therapeutic strategy in the hypertension of Cushing's disease].
Vidal-Trecan G; Luton JP; Mouveroux F; Bricaire H
Ann Med Interne (Paris); 1983; 134(3):249-50. PubMed ID: 6625422
[TBL] [Abstract][Full Text] [Related]
25. Adrenal and pituitary effects of mitotane in Cushing's syndrome.
Kasperlik-Załuska A; Jeske W; Migdalska B
Endokrynol Pol; 1986; 37(1):17-21. PubMed ID: 3015579
[No Abstract] [Full Text] [Related]
26. [Virilizing adrenal carcinoma: exeresis and successful treatment with op'DDD].
Capdevila Sánchez J; Pavía Sesma C; Vila Torres J; Valls Tolosa C; Albarrán Deogracias J
An Esp Pediatr; 1993 Apr; 38(4):351-4. PubMed ID: 8480949
[No Abstract] [Full Text] [Related]
27. [Treatment of Cushing's syndrome and adrenal cancer with O,p-DDD].
Kinouchi T; Shimizu N; Ibayashi H; Demura H; Oshima H
Horumon To Rinsho; 1982 Aug; 30(8):841-51. PubMed ID: 7139984
[No Abstract] [Full Text] [Related]
28. Nelson's syndrome after Cushing's disease in childhood: a continuing problem.
Thomas CG; Smith AT; Benson M; Griffith J
Surgery; 1984 Dec; 96(6):1067-77. PubMed ID: 6505960
[TBL] [Abstract][Full Text] [Related]
29. Pathophysiology and treatment of Cushing's disease.
Krieger DT
Prog Clin Biol Res; 1982; 87():19-32. PubMed ID: 7051030
[No Abstract] [Full Text] [Related]
30. [Disclosure of a pituitary microadenoma during treatment of Cushing's disease].
Simonin R; Heim M; Grisoli F; Brindisi G
Nouv Presse Med; 1981 Jan; 10(4):256. PubMed ID: 7465368
[No Abstract] [Full Text] [Related]
31. [Treatment of Cushing's disease with o, p'-DDD (author's transl)].
Nakagawa K; Ito S; Ohara T; Kubo M; Horikawa H
Horumon To Rinsho; 1981 Sep; 29(9):1135-9. PubMed ID: 7326856
[No Abstract] [Full Text] [Related]
32. Cushing's disease: the role of adrenalectomy and autotransplantation.
Prinz RA; Brooks MH; Lawrence AM; Paloyan E
Surg Clin North Am; 1979 Feb; 59(1):159-65. PubMed ID: 451791
[No Abstract] [Full Text] [Related]
33. [Gynecomastia during long term treatment of Cushing's disease with OP'DDD].
Luton JP; Valcke JC; Remy JM; Mathieu de Fossey B; Bricaire H
Ann Endocrinol (Paris); 1972; 33(3):290-3. PubMed ID: 4650589
[No Abstract] [Full Text] [Related]
34. Effect of mitotane on Alternaria alternata infection in Cushing's syndrome.
Kasperlik-Zaluska AA; Bieluńska S
Lancet; 1991 Jan; 337(8732):53-4. PubMed ID: 1670675
[No Abstract] [Full Text] [Related]
35. [Hepatotoxicity of a synthetic cortisol antagonist: OP'DDD (mitotane)].
Neuman O; Bruckert E; Chadarevian R; Jacob N; Turpin G
Therapie; 2001; 56(6):793-7. PubMed ID: 11878112
[TBL] [Abstract][Full Text] [Related]
36. [Letter: Idiopathic hemochromatosis and Cushing's disease].
Schrub JC; Courtois H
Nouv Presse Med; 1975 Mar; 4(13):972-3. PubMed ID: 1144042
[No Abstract] [Full Text] [Related]
37. [Medical treatment of Cushing syndrome].
Mantero F; Sonino N
Minerva Endocrinol; 1990; 15(1):17-21. PubMed ID: 2274010
[TBL] [Abstract][Full Text] [Related]
38. [Urinary creatine and creatinine excretion in patients with Cushing's disease treated by adrenalectomy].
Przybyszowski A; Lejman W; Adamczyk B
Pol Przegl Chir; 1979 Feb; 51(2):161-6. PubMed ID: 450802
[No Abstract] [Full Text] [Related]
39. Clotting changes in Cushing's syndrome: elevated factor VIII activity.
Dal Bo Zanon R; Fornasiero L; Boscaro M; Ruffato G; Luzzato G; Fabris F; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):268-77. PubMed ID: 6194060
[TBL] [Abstract][Full Text] [Related]
40. Mitotane. Spironolactone antagonism in Cushing's syndrome.
Wortsman J; Soler NG
JAMA; 1977 Dec; 238(23):2527. PubMed ID: 578890
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
